Neil Fanger
Fondateur chez Rise Therapeutics LLC
Provenance du réseau au premier degré de Neil Fanger
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Rise Therapeutics LLC
 Rise Therapeutics LLC BiotechnologyHealth Technology Rise Therapeutics LLC develops immunological-based biologics using proprietary oral delivery platform. It offers drugs for the treatment of inflammation, autoimmunity, and cancer. The company was founded by Gary Fanger and Neil Fanger on September 4, 2014 and is headquartered in Rockville, MD.
1
| Holding Company | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Neil Fanger via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Corporate Officer/Principal | |
EpicentRx, Inc.
 EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| Dartmouth College | College/University | Doctorate Degree | |
| Denison University | College/University | Undergraduate Degree | |
| Seattle University | College/University | Masters Business Admin | |
OncoImmune, Inc.
 OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 8 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 2 |
| Masters Business Admin | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Gary Fanger | 8 |
- Bourse
- Insiders
- Neil Fanger
- Connexions Sociétés
